Bank of Nova Scotia
IPXL

Bank of Nova Scotia’s Impax Laboratories, Inc. IPXL Stock Holding History

Bank of Nova Scotia’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-212,800
Closed -$4.14M – 999
2018
Q1 		$4.14M Buy
+212,800
New +$4.18M 0.02% 422

Bank of Nova Scotia's IPXL Position: Q2 2018 in Review

Bank of Nova Scotia sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 212,800 shares — an estimated $4.14M sold.

Bank of Nova Scotia first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $4.14M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Bank of Nova Scotia reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of Nova Scotia sold 212,800 Impax Laboratories, Inc. shares in Q2 2018, an estimated $4.14M.
  • Bank of Nova Scotia first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
  • Bank of Nova Scotia's Impax Laboratories, Inc. position peaked at $4.14M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Bank of Nova Scotia's 13F filing for Q2 2018, filed 14 Aug 2018.